Burkehill Global Management’s MapLight Therapeutics MPLT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPLT
BBA
Burkehill Global Management's MPLT Position: Q3 2026 in Review
Burkehill Global Management sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 75,000 shares — an estimated $2.69M sold.
Burkehill Global Management first reported a position in MPLT in Q4 2025 and held it in 3 quarters. The position peaked at $2.69M in Q2 2026. 98 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.
- Burkehill Global Management reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
- Burkehill Global Management sold 75,000 MapLight Therapeutics shares in Q3 2026, an estimated $2.69M.
- Burkehill Global Management first reported a position in MapLight Therapeutics in Q4 2025 and held it in 3 quarters.
- Burkehill Global Management's MapLight Therapeutics position peaked at $2.69M in Q2 2026.
- 98 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.
Based on Burkehill Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.